Overview
Dr. Stephan Rau advises investors, Healthcare service providers, pharmaceutical and MedTech companies, as well as governmental entities on M&A transactions, outsourcing projects, and licensing and reimbursement proceedings. He focuses his practice on mergers and acquisitions (M&A) transactions and regulatory advice in the Health and Life Science sector.
He is the head of the Firm’s Health Law Practice Group in Europe.
Stephan speaks regularly at Healthcare and Life Sciences industry as well as legal expert conferences, both at an international and national level. He is the author of numerous publications on German corporate law, Healthcare, and Life Sciences regulation. Prior to joining McDermott, he worked for international law firms in Moscow, Hamburg, and Berlin.
Results
Stephan advised:
- On investments in the clinical lab, renal care, hospital, pharma, medical device, biotech, food, and online pharmacy businesses
- On various outsourcing projects, such as joint ventures between one of the largest medical schools in Europe and a large public hospital carrier leading to the establishment of the largest European clinical lab
- Dialysis service providers on challenging market entry barriers under the German system of determination of need of the statutory health insurance system
- On disease management agreements with statutory health insurance funds
- On one of the largest public tenders for pharmaceuticals by the largest German public payer
- On compulsory early benefit assessments for new pharmaceutical products and related price negotiations under the Pharmaceuticals Market Reorganization Act (Arzneimittelmarkt-Neuordnungsgesetz (AMNOG)) proceedings
Recognitions
- Handelsblatt/Best Lawyers™ Germany 2023: “Lawyer of the Year” in Biotechnology Law and Life Sciences Practice; Leading Lawyer for Biotechnology Law and Life Sciences Practice, Mergers and Acquisitions Law, Healthcare Law, and Pharmaceuticals Law
- Who’s Who Legal 2022: Global Elite Thought Leader Healthcare
- Chambers Europe 2022: Leading Individual, since 2011 continuously ranked Band 1 for Healthcare
- The Legal 500 EMEA 2021-2022: Leading Individual for Healthcare and Life Sciences
- Handelsblatt/Best Lawyers™ Germany 2022: Leading Lawyer for Mergers and Acquisitions Law and Pharmaceuticals Law
- JUVE Handbuch Wirtschaftskanzleien: Frequently recommended lawyer for Corporate, M&A, and Private Equity, and distinguished advisor for Health Services
- Chambers Europe 2023, Band 1 in Germany: Healthcare
- Who’s Who Legal 2021: Life Sciences and Healthcare
- Handelsblatt/Best Lawyers™ Germany 2021: “Lawyer of the Year” in Pharmaceuticals Law
- Expert Guides, Best of the Best 2018-2019: Regulatory, Finance & Transactional, Germany
- Leaders League’s 2019 guide, Innovation, Technology & Patents: “Excellent” in the Health, Pharma & Biotechnology category
- Handelsblatt/Best Lawyers™ Germany 2019: Recommended for Mergers & Acquisitions
- The Legal 500 2017: Recommended Individual for Corporate M&A
- LMG Life Sciences: Life Science Star
Community
Credentials
Education
Humboldt University of Berlin, Dr. jur., 2003
Higher Court of Appeal, Berlin, Second State Exam, 1998
University of Heidelberg, First State Exam, 1996
University of Paris-Dauphine, Maîtrise en Économie Appliquée, 1994
London School of Economics and Political Science, Master of Science in Government, 1993
IHK Wiesbaden, interpreter and translator for Russian, 1990
